All In Biotech

Investigational drug · Phase 2

TX000045

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction, Hypertension, Pulmonary.

Phase 2

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

2

Any phase or sponsor naming "TX000045"

First trial start

2024

Sep 4, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "TX000045", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Pulmonary Hypertension
  • Heart Failure With Preserved Ejection Fraction
  • Hypertension, Pulmonary
  • Lung Diseases, Interstitial

Approved drugs for the same conditions: High blood pressure (hypertension) · Heart failure · Cardiovascular and metabolic

Largest trials

Live from ClinicalTrials.gov: studies naming "TX000045" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 1 on PubMed

Also in development for Pulmonary Hypertension

  • INS1009Treprostinil PalmitilPhase 37 trials

    Insmed Incorporated · Interstitial Lung Disease, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • TNX-103Phase 33 trials

    Tenax Therapeutics, Inc. · Pulmonary Hypertension Associated With HFpEF, Pulmonary Hypertension

  • MosliciguatPhase 32 trials

    Pulmovant, Inc. · Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases

  • RalinepagAPD811Phase 32 trials

    United Therapeutics · PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • HS235Phase 22 trials

    35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.